How do mutated oncogenes and tumor suppressor genes cause cancer?

Medical Oncology

Volumn 15, Issue 1, 1998, Pages 20-26

  Grandér, Dan ^a   Grander G ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Apoptosis; Differentiation; Oncogenes; Proliferation; Senescence; Tumor suppressor genes

Indexed keywords

CYCLIN D1; CYCLIN DEPENDENT KINASE; CYTOKINE; FAS ANTIGEN; INTERFERON; ONCOPROTEIN; PROTEIN BCL 2; PROTEIN P16; RETINOBLASTOMA PROTEIN; TUMOR NECROSIS FACTOR;

APOPTOSIS; CANCER CELL; CELL DIFFERENTIATION; CELL PROLIFERATION; GENE ACTIVATION; GENE MUTATION; HUMAN; MALIGNANT TRANSFORMATION; ONCOGENE; PRIORITY JOURNAL; REVIEW; SENESCENCE; TUMOR SUPPRESSOR GENE;

EID: 0031862654     PISSN: 07360118     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02787340     Document Type: Review

References (17)

1. Palmero I, Peters G. Perturbation of cell cycle regulators in human cancer. Cancer Surv 1996; 27: 351-367.
2. Wyllie AH. Apoptosis and carcinogenesis. Eur J Cell Biol 1997; 73: 189-197.
3. Hayflick L. The limited in vitro lifetime of human diploid strains. Exp Cell Res 1965; 37: 614-636.
4. Campisi J. Replicative senescence: An old live's tale?. Cell 1996; 84: 497-500.
5. Cleaver JE. It was a very good year for DNA repair. Cell 1994; 76: 1-4.
6. Graña X, Reddy EP. Cell cycle control in mammalian cells: role of cyclins, cyclin dependent kinases (CDKs), growth suppressor genes and cyclin-dependent kinase inhibitors (CKIs). Oncogene 1995; 11: 211-219.
7. Pardee AB. G-1 events and regulation of cell proliferation. Science 1989; 246: 603-608.
8. Kamb A, Gruis NA, Weaver-Feldhaus J. A cell cycle regulator potentially involved in genesis of many tumor types. Science 1994; 264: 436-440.
9. Yang E, Korsmeyer SJ. Molecular thanatopsis: A discourse on the BCL2 family and cell death. Blood 1996; 88: 386-401.
10. Whyte M. ICE/CED-3 proteases in apoptosis. Cell Biol 1996; 6: 245-248.
11. Fraser A, Evan G. A license to kill. Cell 1996; 85: 781-784.
12. Vogelstein B, Kinzler KW. p53 function and dysfunction. Cell 1992; 70: 523-526.
13. Olsson I, Bergh G, Ehinger M, Gullberg U. Cell differentiation in acute myeloid leukaemia. Eur J Hematol 1997; 57: 1-16.
14. Sachs L. Control of normal cell differentiation and the phenotypic reversion of malignancy in myeloid leukaemia. Nature 1978; 274: 535.
15. Alcorta DA. et al. Involvement of the cyclin-dependent kinase inhibitor p16 (INK4a) in replicative senescence of normal human fibroblasts. Proc Nat Acad Sci USA 1996; 93: 13742-13747.
16. Harley CB, Villeponteau B. Telomeres and telomerase in aging and cancer. Current Opinion in Genetics & Development 1995; 5: 249-255.
17. Jones JL, Walker RA. Cell-cell and cell-stromal interactions in breast cancer invasion and metastasis. International Journal of Oncology 1997; 11: 609-616.